GENSIA BEGINS SHIPPING GENERIC INJECTABLE ETOPOSIDE
Executive Summary
GENSIA BEGINS SHIPPING GENERIC INJECTABLE ETOPOSIDE following a Feb. 10 ANDA approval for the cancer drug. The San Diego-based company is the first to be cleared to market generic etoposide since patent exclusivity for Bristol-Myers Squibb's VePesid ended Nov. 10, 1993.